These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Management of multiple myeloma in the relapsed/refractory patient]. Tabayashi T Rinsho Ketsueki; 2019; 60(9):1257-1264. PubMed ID: 31597851 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic advances in relapsed or refractory multiple myeloma. Anderson KC J Natl Compr Canc Netw; 2013 May; 11(5 Suppl):676-9. PubMed ID: 23704241 [TBL] [Abstract][Full Text] [Related]
6. Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat. Afifi S; Michael A; Azimi M; Rodriguez M; Lendvai N; Landgren O Pharmacotherapy; 2015 Dec; 35(12):1173-88. PubMed ID: 26684557 [TBL] [Abstract][Full Text] [Related]
7. Modern Treatments and Future Directions for Relapsed/Refractory Multiple Myeloma Patients. Premkumar V; Bhutani D; Lentzsch S Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):736-743. PubMed ID: 32739311 [TBL] [Abstract][Full Text] [Related]
8. Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma. Pantani L; Brioli A; Tacchetti P; Zannetti BA; Mancuso K; Rocchi S; Martello M; Rizzello I; Terragna C; Zamagni E; Cavo M Expert Rev Hematol; 2016 Mar; 9(3):315-23. PubMed ID: 26634945 [TBL] [Abstract][Full Text] [Related]
9. The future of therapy for relapsed/refractory multiple myeloma: emerging agents and novel treatment strategies. Moreau P Semin Hematol; 2012 Jul; 49 Suppl 1():S33-46. PubMed ID: 22727391 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Relapsed/Refractory Multiple Myeloma. Neri P; Bahlis NJ; Paba-Prada C; Richardson P Cancer Treat Res; 2016; 169():169-194. PubMed ID: 27696263 [TBL] [Abstract][Full Text] [Related]
11. [Treatment strategy for relapsed or refractory myeloma according to the new Guidelines]. Ozaki S Rinsho Ketsueki; 2018; 59(10):2178-2188. PubMed ID: 30305524 [TBL] [Abstract][Full Text] [Related]
12. Emerging therapies for the treatment of relapsed or refractory multiple myeloma. Dimopoulos MA; San-Miguel JF; Anderson KC Eur J Haematol; 2011 Jan; 86(1):1-15. PubMed ID: 20942854 [TBL] [Abstract][Full Text] [Related]
13. [Current treatment of refractory and relapsed multiple myeloma]. Sasaki M Rinsho Ketsueki; 2016; 57(10):2084-2095. PubMed ID: 27795518 [TBL] [Abstract][Full Text] [Related]